We did a population-based observational investigation named survey on prevalence in East China for metabolic diseases and risk factors (SPECT-China) in 2014 to analyze this association between FSH and type 2 DM in Chinese postmenopausal women older than 55 years. This evidence concerns the gene BRD2 and metabolic disease.